Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner bought 50,000 shares of the business’s stock in a transaction on Wednesday, May 17th. The shares were acquired at an average cost of $13.07 per share, with a total value of $653,500.00. Following the purchase, the insider now owns 6,954,000 shares of the company’s […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating)’s stock price was up 3.3% on Tuesday following insider buying activity. The company traded as high as $13.33 and last traded at $13.33. Approximately 164,464 shares traded hands during trading, a decline of 76% from the average daily volume of 678,851 shares. The stock had previously closed at $12.91. […]
StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Get Rating) from a hold rating to a buy rating in a research note published on Thursday morning. Several other analysts have also recently issued reports on the company. TheStreet cut Innoviva from a b- rating to a c+ rating in a research note on Thursday, February 23rd. […]
Robeco Institutional Asset Management B.V. raised its holdings in Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 0.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 520,899 shares of the biotechnology company’s stock after buying an additional 1,619 shares during the period. Robeco Institutional […]
Los Angeles Capital Management LLC lessened its position in shares of Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 184,008 shares of the biotechnology company’s stock after selling 1,594 shares during […]